Patents by Inventor Kartik Chandran

Kartik Chandran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230138323
    Abstract: A command line interface in a network device provides for specifying Virtual Local Area Network (VLAN) tag manipulations using range mappings to avoid error-prone repetitive configuration. A flexible VLAN tag range mapping is described, where the original and transformed ranges can be specified for both inner and outer positions, as long as the number of tags on either side of the transformation is the same.
    Type: Application
    Filed: November 2, 2021
    Publication date: May 4, 2023
    Inventors: Nicholas TAN, Wade CARPENTER, Kartik CHANDRAN, Adam James SWEENEY, Chandrashekhar APPANNA, Christoph SCHWARZ, Victor WEN
  • Patent number: 11588756
    Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.
    Type: Grant
    Filed: January 20, 2022
    Date of Patent: February 21, 2023
    Assignee: Arista Networks, Inc.
    Inventors: Francois Labonte, Kartik Chandran, Eswaran Baskaran, Hugh Weber Holbrook
  • Publication number: 20230044044
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Application
    Filed: July 1, 2022
    Publication date: February 9, 2023
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Wec, Laura Walker
  • Publication number: 20230000979
    Abstract: Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.
    Type: Application
    Filed: May 31, 2022
    Publication date: January 5, 2023
    Inventors: Zachary A. Bornholdt, Akaash Mishra, Laura M. Walker, Noel T. Pauli, Daniel Maurer, Kartik Chandran, Jens Maximilian Fels, Dafna Abelson, Jason Scott McLellan, Jonathan R. Lai, Ariel Wirchnianski, Olivia Vergnolle, John M. Dye, Andrew S. Herbert
  • Patent number: 11459308
    Abstract: The present invention is related to the development of therapeutics and prophylactics for the treatment and/or prevention of filovirus infection in humans and other mammals. A new class of small molecules is disclosed that inhibits the interaction of naturally processed (i.e., proteolytically cleaved) filovirus glycoprotein (GPCL) with its host receptor Niemann-Pick C1 (NPC1) protein and thus block infection of host cells by filoviruses. Also disclosed are methods of using the small molecule inhibitors in the treatment/prevention of filovirus infection.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: October 4, 2022
    Assignees: Microbiotix, Inc., Albert Einstein College of Medicine, The Government of the United States as Represented by the Secretary of the Army
    Inventors: Terry L. Bowlin, Donald T. Moir, Kartik Chandran, John M. Dye, Jr., John D. Williams, Zachary D. Aron, Jay P. Barbor, Kelly N. Lively, Peter J. Nash, Debra M. Mills, Arnab Basu
  • Patent number: 11407817
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: August 9, 2022
    Assignees: MAPP BIOPHARMACEUTICAL, INC., ALBERT EINSTEIN COLLEGE OF MEDICINE, ADIMAB, LLC
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Z. Wec, Laura Walker
  • Patent number: 11407816
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially, similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: August 9, 2022
    Assignees: MAPP BIOPHARMACEUTICAL, INC., ALBERT EINSTEIN COLLEGE OF MEDICINE, ADIMAB, LLC
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Wec, Laura Walker
  • Publication number: 20220150186
    Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.
    Type: Application
    Filed: January 20, 2022
    Publication date: May 12, 2022
    Inventors: Francois LABONTE, Kartik CHANDRAN, Eswaran BASKARAN, Hugh Weber HOLBROOK
  • Patent number: 11283733
    Abstract: Methods and systems for modifying network traffic data. The method of modifying network traffic may include receiving a network traffic data unit that includes an identifier, at a proxy port; based on the identifier, performing a proxy port action set to obtain a modified network traffic data unit; and transmitting the modified network traffic data unit towards an egress port.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: March 22, 2022
    Assignee: Arista Networks, Inc.
    Inventors: Dipankar Bhatt Acharya, Kartik Chandran, Hugh W. Holbrook, François Labonté, Sambath Kumar Balasubramanian
  • Patent number: 11265269
    Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: March 1, 2022
    Assignee: Arista Networks, Inc.
    Inventors: Francois Labonte, Kartik Chandran, Eswaran Baskaran, Hugh Weber Holbrook
  • Patent number: 11254732
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: February 22, 2022
    Assignees: MAPP BIOPHARMACEUTICAL, INC., ALBERT EINSTEIN COLLEGE OF MEDICINE, ADIMAB, LLC
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Wec, Laura Walker
  • Patent number: 11242379
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: February 8, 2022
    Assignees: MAPP BIOPHARMACEUTICAL, INC., ALBERT EINSTEIN COLLEGE OF MEDICINE, ADIMAB, LLC
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Wec, Laura Walker
  • Patent number: 11242378
    Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially, similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: February 8, 2022
    Assignees: MAPP BIOPHARMACEUTICAL, INC., ALBERT EINSTEIN COLLEGE OF MEDICINE, ADIMAB, LLC
    Inventors: Zachary A. Bornholdt, Larry Zeitlin, Kartik Chandran, Anna Wec, Laura Walker
  • Publication number: 20210355195
    Abstract: Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 18, 2021
    Inventors: Zachary A. Bornholdt, Akaash Mishra, Laura M. Walker, Noel T. Pauli, Daniel Maurer, Kartik Chandran, Jens Maximilian Fels, Dafna Abelson, Jason Scott McLellan, Jonathan R. Lai, Ariel Wirchnianski, Olivia Vergnolle
  • Patent number: 11149080
    Abstract: Disclosed are bispecific antibodies and bispecific fusion constructs that bind to Niemann-Pick C1 (NPC1) receptor for treating or preventing filovirus infections, pharmaceutical compositions comprising the bispecific antibodies, and therapeutic methods using the bispecific antibodies.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: October 19, 2021
    Assignee: Albert Einstein College of Medicine
    Inventors: Kartik Chandran, Anna Z. Wec, Elisabeth K. Nyakatura, Jonathan R. Lai
  • Publication number: 20210292394
    Abstract: The present invention addresses a need for antibodies useful for filovirus infections.
    Type: Application
    Filed: December 28, 2020
    Publication date: September 23, 2021
    Inventors: Jonathan R. Lai, Jayne F.. Koellhoffer, Julia Frei, Kartik Chandran, Sachdev Sidhu, Gang Chen, John M. Dye, Samantha Zak
  • Publication number: 20210273891
    Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 2, 2021
    Inventors: Francois LABONTE, Kartik CHANDRAN, Eswaran BASKARAN, Hugh Weber HOLBROOK
  • Publication number: 20210092103
    Abstract: Methods and systems for modifying network traffic data. The method of modifying network traffic data may include receiving a network traffic data unit by a switching engine; performing an analysis on the network traffic data unit to obtain network tunnel information; generating encryption information based on the network tunnel information; and securing the network traffic data unit, by an encryption engine, based on the encryption information.
    Type: Application
    Filed: October 1, 2019
    Publication date: March 25, 2021
    Inventors: Dipankar Bhatt Acharya, Kartik Chandran, Hugh W. Holbrook, François Labonté, Sambath Kumar Balasubramanian
  • Patent number: 10947141
    Abstract: Methods and systems for controlling a denitrification reaction in a biological nitrogen removal reactor including denitrifying bacteria to favor denitratation of nitrate to nitrite and limit denitritation of nitrite to nitrogen gas are disclosed. pH, dissolved oxygen levels, solids retention time, and chemical oxygen demand to nitrogen ratio are controlled to favor this reaction. Wastewater or contaminated groundwater including concentrations of ammonium and nitrate are continuously fed to the biological nitrogen removal reactor along with a source of carbon and electrons as an influent, which is treated to form a nitrite effluent. The nitrite effluent may then be fed to an anammox reactor including anammox bacteria for production of nitrogen gas. The system may be operated under substantially anoxic conditions, which provides significant cost savings without sacrificing efficiency or productivity compared to traditional wastewater treatment systems and processes.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: March 16, 2021
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Kartik Chandran, Luke Plante
  • Patent number: 10875907
    Abstract: The present invention addresses a need for antibodies useful for filovirus infections.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: December 29, 2020
    Assignees: Albert Einstein College of Medicine, The Governing Council of the University of Toronto, The Government of the United States as Represented by the Secretary of the Army
    Inventors: Jonathan R. Lai, Jayne F. Koellhoffer, Julia Frei, Kartik Chandran, Sachdev Sidhu, Gang Chen, John M. Dye, Samantha Zak